Research ArticlePediatric Rheumatology
Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry
MARIA E. ZANNIN, CAROLINA BIROLO, VALERIA M. GERLONI, ELISABETTA MISEROCCHI, IRENE PONTIKAKI, MARIA P. PAROLI, CLAUDIA BRACAGLIA, ALISON SHARDLOW, FULVIO PARENTIN, ROLANDO CIMAZ, GABRIELE SIMONINI, FERNANDA FALCINI, FABRIZIA CORONA, STEFANIA VIOLA, RICCARDO DE MARCO, LUCIANA BREDA, FRANCESCO LA TORRE, FABIO VITTADELLO, GIORGIA MARTINI and FRANCESCO ZULIAN
The Journal of Rheumatology January 2013, 40 (1) 74-79; DOI: https://doi.org/10.3899/jrheum.120583
MARIA E. ZANNIN
From the Ophthalmology and Rheumatology Units, Department of Pediatrics, University of Padua, University of Milan (G. Pini Institute), University of Rome (Ocular Immunovirology Service, Sapienza University), University of Rome (Bambino Gesù Children’s Hospital), University of Trieste (Burlo Garofalo Children’s Hospital), University of Florence (A. Meyer Children’s Hospital), University of Florence (Department of Internal Medicine, Rheumatology, Transition Clinic), University of Milan (Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico), University of Genoa (G. Gaslini Children’s Hospital), University of Chieti (University Hospital), and University of Messina (University Hospital),
Italy.
CAROLINA BIROLO
VALERIA M. GERLONI
ELISABETTA MISEROCCHI
IRENE PONTIKAKI
MARIA P. PAROLI
CLAUDIA BRACAGLIA
ALISON SHARDLOW
FULVIO PARENTIN
ROLANDO CIMAZ
GABRIELE SIMONINI
FERNANDA FALCINI
FABRIZIA CORONA
STEFANIA VIOLA
RICCARDO DE MARCO
LUCIANA BREDA
FRANCESCO LA TORRE
FABIO VITTADELLO
GIORGIA MARTINI
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 40, Issue 1
1 Jan 2013
Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry
MARIA E. ZANNIN, CAROLINA BIROLO, VALERIA M. GERLONI, ELISABETTA MISEROCCHI, IRENE PONTIKAKI, MARIA P. PAROLI, CLAUDIA BRACAGLIA, ALISON SHARDLOW, FULVIO PARENTIN, ROLANDO CIMAZ, GABRIELE SIMONINI, FERNANDA FALCINI, FABRIZIA CORONA, STEFANIA VIOLA, RICCARDO DE MARCO, LUCIANA BREDA, FRANCESCO LA TORRE, FABIO VITTADELLO, GIORGIA MARTINI, FRANCESCO ZULIAN
The Journal of Rheumatology Jan 2013, 40 (1) 74-79; DOI: 10.3899/jrheum.120583
Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry
MARIA E. ZANNIN, CAROLINA BIROLO, VALERIA M. GERLONI, ELISABETTA MISEROCCHI, IRENE PONTIKAKI, MARIA P. PAROLI, CLAUDIA BRACAGLIA, ALISON SHARDLOW, FULVIO PARENTIN, ROLANDO CIMAZ, GABRIELE SIMONINI, FERNANDA FALCINI, FABRIZIA CORONA, STEFANIA VIOLA, RICCARDO DE MARCO, LUCIANA BREDA, FRANCESCO LA TORRE, FABIO VITTADELLO, GIORGIA MARTINI, FRANCESCO ZULIAN
The Journal of Rheumatology Jan 2013, 40 (1) 74-79; DOI: 10.3899/jrheum.120583